Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 86.21 USD 1.73% Market Closed
Market Cap: 110.6B USD
Have any thoughts about
Medtronic PLC?
Write Note

Operating Margin
Medtronic PLC

18.9%
Current
20%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
6.1B
/
Revenue
32.6B

Operating Margin Across Competitors

Country IE
Market Cap 110.6B USD
Operating Margin
19%
Country US
Market Cap 204.9B USD
Operating Margin
17%
Country US
Market Cap 195.2B USD
Operating Margin
26%
Country US
Market Cap 146.7B USD
Operating Margin
22%
Country US
Market Cap 132.6B USD
Operating Margin
18%
Country US
Market Cap 64.7B USD
Operating Margin
14%
Country DE
Market Cap 55.6B EUR
Operating Margin
12%
Country CN
Market Cap 319.2B CNY
Operating Margin
37%
Country US
Market Cap 41.6B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
Country US
Market Cap 35.8B USD
Operating Margin
30%
No Stocks Found

Medtronic PLC
Glance View

Market Cap
110.6B USD
Industry
Health Care

Medtronic PLC, a powerhouse in the global medical technology sector, was established in 1949 and has since evolved into a key player in advancing healthcare through innovative solutions. Headquartered in Dublin, Ireland, Medtronic operates across numerous medical areas, including cardiovascular, diabetes, neurological, and surgical technologies. Their commitment to improving patient outcomes is evident in their diverse product portfolio, which includes groundbreaking devices such as insulin pumps, heart valves, and spinal implants. With a presence in over 150 countries and a robust supply chain, Medtronic is strategically positioned to address the increasing demand for healthcare solutions driven by an aging population and the growing prevalence of chronic diseases. For investors, Medtronic represents a compelling opportunity backed by strong financial fundamentals and a commitment to continuous innovation. The company has demonstrated consistent revenue growth and profitability, driven by investments in research and development that align with emerging healthcare trends. Their focus on strategic acquisitions and partnerships enhances their competitive edge, enabling them to expand into new markets and technologies. Furthermore, Medtronic's commitment to sustainability and corporate responsibility resonates with today’s socially-conscious investors. As healthcare evolves, Medtronic stands poised to lead the charge in transforming patient care, making it a worthy consideration for those looking to invest in the future of medical technology.

MDT Intrinsic Value
100.49 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
6.1B
/
Revenue
32.6B
What is the Operating Margin of Medtronic PLC?

Based on Medtronic PLC's most recent financial statements, the company has Operating Margin of 18.9%.